Best have a read of their CLBP patent application:
https://patents.google.com/patent/WO2019023761A1/en?q=Pentosan
- Forums
- ASX - By Stock
- Application
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.23%
!
45.0¢

Best have a read of their CLBP patent...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $180.8M |
Open | High | Low | Value | Volume |
47.0¢ | 47.5¢ | 43.0¢ | $286.6K | 630.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4933 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.5¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7253 | 0.455 |
8 | 142076 | 0.450 |
1 | 8166 | 0.445 |
4 | 27668 | 0.440 |
5 | 23511 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 80139 | 2 |
0.470 | 121674 | 4 |
0.475 | 43376 | 4 |
0.480 | 107895 | 5 |
0.485 | 32794 | 3 |
Last trade - 11.51am 07/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online